Startups
Infertility treatment - Receptiva DX is a first-of-its-kind test for the detection of endometriosis, a leading cause of infertility.
Overview
Location
United States, California, Huntington Beach
Employees
11-50
Phone
+880 1309-913633
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 31, 2022 | Cicero Diagnostics Partners with Mediaplanet to Help Educate Women Contemplating IVF About its ReceptivaDx Test | “Cicero Diagnostics recognizes the importance of education at both the physician and patient level. Our goals are to meet both groups’ needs with clinically relevant and actionable information...” HUNTINGTON BEACH, Calif. (PRWEB) March 31, ... |
| Sep 16, 2021 | Cicero Diagnostics to Partner with Mediaplanet a Second Time in a Campaign to Educate Women Contemplating IVF About its ReceptivaDX Test | “Cicero Diagnostics recognizes the importance of education at both the physician and patient level. Our goals are to meet both groups’ needs with clinically relevant and actionable information.” -CEO, Chris Jackson HUNTINGTON BEACH, Calif. ... |
Reviews 0
FAQ about ReceptivaDx
What has the press written about ReceptivaDx?
Parsers VC has collected 3 articles mentioning ReceptivaDx, among them “Cicero Diagnostics Partners with Mediaplanet to Help Educate Women Contemplating IVF About its ReceptivaDx Test” (Mar 31, 2022) and “Cicero Diagnostics to Partner with Mediaplanet a Second Time in a Campaign to Educate Women Contemplating IVF About its ReceptivaDX Test” (Sep 16, 2021).
Is ReceptivaDx still active?
Yes, ReceptivaDx is active; its latest activity on Parsers VC dates from May 16, 2024.